Effects of epinephrine and the cyclic AMP phosphodiesterase inhibitor SQ 20009 on glucose and glycogen metabolism in skeletal muscle.
D000818:Animals; D002118:Calcium / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology*; D004974:Etazolate / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D005958:Glucosephosphates / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000378:metabolism*; D009539:Nicotinic Acids / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013015:Sotalol / Q000494:pharmacology; D013997:Time Factors
D005958:Glucosephosphates; D009539:Nicotinic Acids; D006003:Glycogen; D011433:Propranolol; D013015:Sotalol; D004974:Etazolate; D005947:Glucose; D002118:Calcium; D004837:Epinephrine; D010646:Phentolamine